Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 20Neoplasms 9Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Solid Malignancies 1Recurrence 1Pancreatic Neoplasms 1Lung Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma 1Advanced Solid Tumors 1Adenocarcinoma Of Esophagus 1

Interventions

Carboplatin 367Pemetrexed 308pembrolizumab 302Cisplatin 242Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 78atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28cemiplimab 26tislelizumab 25avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × ixabepilone × Clear all
NCT00723957 2020-10-28

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

R-Pharm

Phase 2 Completed
260 enrolled 17 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00832117 2020-10-28

Phase I Combination Ixabepilone + Cisplatin

R-Pharm

Phase 1 Completed
30 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00683904 2016-03-10

Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer

R-Pharm

Phase 1 Completed
12 enrolled 20 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡